Principal Financial Group’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-21,034
Closed -$442K 2291
2024
Q2
$442K Buy
21,034
+1,849
+10% +$38.8K ﹤0.01% 1984
2024
Q1
$611K Buy
19,185
+9,204
+92% +$293K ﹤0.01% 1944
2023
Q4
$202K Sell
9,981
-1,060
-10% -$21.5K ﹤0.01% 2168
2023
Q3
$141K Buy
+11,041
New +$141K ﹤0.01% 2219